Login to Your Account

Actavis' Avycaz approval adds another asset to the antibiotics arsenal

By Marie Powers
Staff Writer

Thursday, February 26, 2015

The FDA approved Avycaz (ceftazidime/avibactam) to treat adults with complicated intra-abdominal infections (cIAIs) and complicated urinary tract infections (cUTIs), offering a promising option to fight drug-resistant superbugs.

To continue reading subscribe now to Latest News

Learn More about Latest News

Already a subscriber? Sign In or Buy now to activate your subscription